• No results found

INITIATING COVERAGE REPORT

N/A
N/A
Protected

Academic year: 2021

Share "INITIATING COVERAGE REPORT"

Copied!
16
0
0

Loading.... (view fulltext now)

Full text

(1)

November 06, 2018

(2)

2 Welspun India (Welspun) is one of the leading manufacturers of terry towels and bed linen. Market share of towels for the company in the US has grown from 15% in CY13 to 19% in CY20 and for bedsheets, from 7% in CY13 to 12% in CY20. This was primarily on account of favourable macro factors like cheap labour in India, availability of cotton and company-specific factors like strong relationships with leading big-box retailers in the US, introducing innovative products and adopting a mix of offline and online sales.

Flooring business to drive growth

The addressable market for flooring in the US was $20bn market in CY20, where China is the market leader in this segment. However trade war between China and the US has impacted prospects for China. This has resulted in new growth opportunities for India. To capture the advantage, the company has spent Rs.1200cr as capex as of Q1FY22 and foresee a potential of Rs.2,400cr turnover over the medium term.

Strong visibility for revenue growth

Many retail companies in the US are looking for alternative locations, following the China+1 theme in home textiles and flooring as well. Welspun is likely to benefit, given its strong presence and tie-ups with big-box retailers in the segments over the years. The company has ventured into B2C, advanced textiles and flooring, which should further drive the growth, going forward.

Y/E Mar Revenue (Rs. Cr)

EBITDA (Rs. Cr)

PAT (Rs. Cr)

NPM (%)

AEPS (Rs.)

P/E (x)

P/B (x)

ROCE (%)

FY20 6,741.1 1,214.7 471.1 7.0 4.7 34.8 5.5 15.0

FY21 7,340.2 1,352.0 539.6 7.4 5.4 30.4 4.5 17.4

FY22E 8,404.5 1,562.0 676.2 8.0 6.7 24.3 3.8 18.9

FY23E 9,180.0 1,729.8 769.8 8.4 7.7 21.3 3.2 18.7

October 12, 2021

Please refer to the disclosure on last page

OUTLOOK & VALUATION

We forecast Welpsun’s revenue/PAT to grow at 11.8%/19.0% CAGR over FY21-23E. Going forward, we expect the company to deliver an EPS of Rs.7.7 in FY23; assigning a target multiple of 28x, we arrive at a target price of Rs.215, showcasing an upside potential of 31% from current levels with an investment horizon of 18-24 months. We recommend a BUY at current levels.

SHARE HOLDING (%)

Promoters 70.0

FII 6.8

FI/Bank 7.2

Body Corporate 2.9

Public & Others 13.1

RESEARCH ANALYST Umesh Matkar | +91 22 4093 4078 [email protected]

SALES:

Devang Shah | +91 22 4093 6060/61 [email protected]

BUY Reuters Code Bloomberg Code

WLSP.BO WLSI IN BSE Code

NSE Symbol

514162 WELSPUNIND

Face Value 1

Shares Outstanding 100.5 Cr Avg. Daily Vol. (6m) 40,68,693 Price Performance (%)

1M 3M 6M

19 55 92

200 Days EMA Rs. 106

(3)

3 Oct. 12, 2021

• Indian companies have grabbed a higher share in US home textiles as compared to others on account of abundant availability of cotton, cheap skilled labour etc. Demand from the US will continue to be high on account of the increase in spending on essentials and home renovation, bounce back in the hospitality sector due to increased spending on travel and holidays recently.

Indian companies focused more on the US, as the duty structure was similar for India and other countries. However imports from India to Europe account for 9-10% of import duty as compared to duty-free access for other countries like Bangladesh and Pakistan.

Source: Company, OTEXA, Sushil Finance Research

(4)

4 Oct. 12, 2021

Leading player in Home textiles (2/2)

• Introduction of products that are new to the market, based on the needs of the consumers have augured well for Welspun.

Innovative products such as hygrocotton technology (provides temperature regulation for bed sheets and towels throughout the year), nano care (fabric structure creates a natural allergen barrier), charcoal (charcoal is infused into a special line of textiles that makes it odor free and hygienic). The share of innovative products in the revenue has risen from 36% in FY17 to 40% in FY21.

• In anticipation of an increase in demand for home textiles, the company is enhancing the capacity at Vapi and Anjar plant in bed linen by 20% to 108m mtrs, 80% increase in rugs to 18m sq mtrs by FY22, through de-bottlenecking and rebalancing facilities.

Towel capacity has also been increased by 7% to 85,400 MT in Q1FY22. It is guided by the management that an increase in revenue from this expansion would be ~Rs.1,200 cr (~20% of revenue as of FY22) by spending ~Rs.225cr in FY21 and FY22.

• The company had entered from B2B to B2C in order to increase the sales penetration in the US and Europe. The US consumer reach is getting stronger with licensed brands like Martha and Scott in the portfolio. The company had acquired UK-based

‘Christy’ in 2006 and since then has been constantly scaling its branded products portfolio. UK/Europe getting stronger with the Christy Brand and India consumer reach is getting enhanced with Spaces and Welspun. The addition of brands gives it additional shelf space, opens up new channels and creates incremental volumes, both online and offline.

• We expect that with the adoption of above strategies, the structural shift in spending in home textiles, adding new products in

its portfolio, increasing the capacity should lead to 7.5% CAGR growth by FY21-23E.

(5)

5 Oct. 12, 2021

Flooring business to drive growth

The global flooring market size is estimated at $290 bn and is expected to expand at a CAGR of 5.9% from FY20 to FY27. The commercial use dominated the market and the demand is expected to be strong on account of rising construction projects for offices, hospitals, educational institutes, health care facilities. On the domestic front, imports dominate commercial and institutional flooring. Thus existing market dynamics provide a huge opportunity for import substitution. Apart from this, flooring products from China are imposed 25% import duty by the US. China used to supply close to 50% of total flooring imports by the US.

As a result, companies in the US are looking out for alternatives in this segment.

In order to capture the opportunity, the company is incurring a capex to set up a flooring plant in Telangana with a capacity of 27mn sq mtrs to be completed by FY22 (of which 13mn sq mtrs is operational as on 1QFY22). Welspun would be the only brand in the market, offering safety & convenience of one-day installation to the consumers. The management is confident of achieving a turnover of Rs.2,400cr by FY24-25 from Rs.319cr in FY21 and EBITDA break-even by Q3FY22.

.

Source: Company Sushil Finance Research

(6)

6 Oct. 12, 2021

Strong visibility for revenue growth

The company has ventured into B2C, advanced textiles and flooring, which should drive higher growth in the future. Advanced textiles business houses a diverse range of products under its portfolio using three major technologies – Spunlace, Needlepunch and Thermobond. In Spunlace the company has a strategic partnership with customers such as P&G & J&J for fem-care products. It entered into the health segment, wherein it makes disposable towels and wet wipes out of non-woven textiles, forayed into disinfectant wipes and surgical masks. It aims to target Rs.600cr of the topline from advanced textiles by FY23E from Rs.285cr in FY21.

Many retail companies in the US are looking for alternatives for China in home textiles and flooring. Welspun is likely to benefit, given its strong presence and tie-up with big box retailers in the segments over the years. We believe capacity expansion in flooring, increase in market share in the US and increase its presence in B2C should result in a topline CAGR of 11.8% for FY21-23E.

Source: Company Sushil Finance Research

(7)

7 Oct. 12, 2021

Welspun India Limited is a global leader in home textiles, supplying to top global retailers. It manufactures a wide range of home textile products like towels, bed sheet, rugs and carpets and flooring solutions at vertically integrated plants in Gujarat and Telangana. Over the years, it has transformed from textile manufacturer to home textiles and recently commenced flooring business.

WIL's distribution network is spanning in more than 50 countries, making it the largest exporter of home textile products from India

For the year ended March 31, 2021, the company recorded a turnover of Rs.7,340 cr (8.9% yoy growth) with an EBITDA margin of 18.4%, as compared to 18.0% in FY20. Despite high capex behind incremental capacity, its net D/E level has improved to 0.64x as in FY21 from 1.33x in FY17.

COMPANY OVERVIEW

(8)

8 Oct. 12, 2021

BUSINESS OVERVIEW: BED LINEN and BATH LINEN

Source: Company, Sushil Finance Research

(9)

9 Oct. 12, 2021

BUSINESS OVERVIEW: FLOORING

Source: Company, Sushil Finance Research

(10)

10 Oct. 12, 2021

KEY CUSTOMERS

Source: Company, Sushil Finance Research

(11)

11 Oct. 12, 2021

FINANCIAL OVERVIEW

Source: Company, Sushil Finance Research

6,051 6,527 6,741 7,340

8,405 9,180

-8.9

7.9

3.3

8.9

14.5

9.2

-15.0 -10.0 -5.0 0.0 5.0 10.0 15.0 20.0

0 5000 10000

2018 2019 2020 2021 2022E 2023E

Revenue

Revenue (Rs in cr.) % yoy

10.4%

6.4% 6.6% 7.0% 7.4% 8.0% 8.4%

2017 2018 2019 2020 2021 2022e 2023e

PAT margin

12.0% 13.1%

15.0%

17.4% 18.9% 18.7%

2018 2019 2020 2021 2022e 2023e

ROCE

3,188

2,961 2,962

3,179

2,716 1.33

1.14 1.07

1.07

0.75

0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40

2,400 2,500 2,600 2,700 2,800 2,900 3,000 3,100 3,200 3,300

FY17 FY18 FY19 FY20 FY21

Debt and Debt/Equity trend

Debt in crs. D/E

(12)

12 Oct. 12, 2021

OUTLOOK & VALUATION

We forecast Welpsun’s revenue/PAT to grow at 11.8%/19.0% CAGR over FY21-23E. Going forward, we expect the company to deliver an EPS of Rs.7.7 in FY23; assigning a target multiple of 28x, we arrive at a target price of Rs.215, showcasing an upside potential of 31% from current levels with an investment horizon of 18-24 months. We recommend a BUY at current levels.

Source: Company, Sushil Finance Research

Price Comparison between Sensex and Welspun India Ltd Price Movement of Welspun India Ltd

Source: Company, Sushil Finance Research , iChart.in

0

10000 20000 30000 40000 50000 60000 70000

0 20 40 60 80 100 120 140 160 180

10/9/2017 10/9/2018 10/9/2019 10/9/2020 Welspun India BSE Sensex

(13)

13 Oct. 12, 2021

RISKS & CONCERNS

• The company passes on the increase in prices of cotton to the customers. Recently apart from the increase in prices of cotton, freight charges have gone up. Management is in talks with customers about price rise. In case, the company is unable to increase prices, margins would be impacted.

• 95-96% of the revenue comes from exports. Any adverse movement in currency may impact the earnings of the company.

• While the current indications are that the second COVID-19 wave may be on the wane, its resurgence or the possibility of a third wave may reverse recovery of macro-economy, domestically as well as globally

Why you should buy?

• Market share gains in the home textile market in the US, pick up in B2C and introduction of new products is likely to drive core home textiles business in the medium term.

• The company expects EBITDA to be at a healthy level of 20-21% in FY22. Rebate of State and Central taxes and Levies (RoSCTL) rate was extended up to March 31, 2024, at 8.2%, which is much higher than expected, 2%. The development is positive for home textile and garment players who derive a sizeable proportion of their profitability via these incentives.

• With the Welspun’s leadership position in the largest exports market (USA) and strong brand recall in the market as well, it is

well placed to benefit from any spillover effect as a result of the ‘China + 1’ strategy and geo-political developments .

(14)

14 Oct. 12, 2021

Source: Company, Sushil Finance Research Estimates

PROFIT & LOSS STATEMENT

(Rs.cr)

BALANCE SHEET STATEMENT

(Rs.cr)

Y/E Mar. FY20 FY21 FY22E FY23E

Net Sales 6,741.1 7,340.2 8,404.5 9,180.0

Raw Material Cost 3,296.3 3,587.3 4,153.1 4,549.3

Employee Cost 778.1 822.8 924.5 1,009.8

Other Expenses 1,452.0 1,578.1 1,764.9 1,891.1

EBITDA 1,214.7 1,352.0 1,562.0 1,729.8

Depreciation 481.1 453.6 479.1 523.3

Interest Cost 177.7 197.5 200.0 200.0

Other Income 95.1 67.8 75.6 82.6

PBT 694.4 768.6 958.5 1,089.1

Tax 170.0 217.9 271.3 308.2

RPAT 471.1 539.6 676.2 769.8

As on 31

st

Mar. FY20 FY21 FY22E FY23E

Equity Share Capital 100.5 100.5 100.5 100.5

Reserves 2,871.6 3,544.2 4,205.3 4,960.0

Net worth 3,056.9 3,743.2 4,409.2 5,169.1

Total loans 3,178.7 2,715.7 2,798.7 2,783.3

Other Current Liabilities 2,074.6 2,218.9 2,408.4 2,581.6

Total Liabilities 8,310.2 8,677.8 9,616.4 10,534.0

Net block 3,632.6 3,511.8 3,621.0 3,740.4

Capital Work-in –Progress 56.4 170.9 588.3 642.6

Deferred tax Asset (net) 116.2 112.0 117.6 123.5

Sundry debtors 1,086.2 1,181.7 1,355.6 1,480.6

Inventories 1,528.7 1,773.1 2,056.0 2,252.1

Cash and bank 230.4 399.1 378.6 404.2

Loans and advances 0.5 0.6 0.6 0.7

Other Assets 322.4 442.2 464.3 487.5

Total Assets 8,310.2 8,677.8 9,616.4 10,534.0

(15)

15 Oct. 12, 2021

CASH FLOW STATEMENT

(Rs.cr)

FINANCIAL RATIO STATEMENT

Y/E Mar. FY20 FY21 FY22E FY23E

PAT 471.1 539.6 676.2 769.8

Depreciation & Amortization 481.1 453.6 479.1 523.3

Taxes 170.0 217.9 271.3 308.2

Finance Cost 177.7 197.5 200.0 200.0

(Incr)/Decr in Working Capital 56.4 (95.5) (324.8) (228.6) Cash Flow from Operating 1356.3 1313.2 1301.6 1572.6

(Incr)/ Decr in Gross PP&E (1041.9) (332.8) (588.3) (642.6) (Incr)/Decr In Investments and

Intangibles 33.5 15.2 (0.1) (0.1)

Others 425.6 (59.9) (384.9) (59.6)

Cash Flow from Investing (582.8) (377.5) (973.3) (702.3)

(Decr)/Incr in Debt 217.0 (463.0) 83.1 (15.5)

Others (832.7) (288.9) (416.9) (814.1)

Cash Flow from Financing (716.2) (767.0) (348.9) (844.7)

Opening Cash 173.0 230.0 399.0 379.0

Total cash flow 57.3 168.7 (20.5) 25.7

Cash at the End of the Year 230.5 399.1 378.6 404.2

Y/E Mar. FY20 FY21 FY22E FY23E

Growth (%)

Total Sales 3.3% 8.9% 14.5% 9.2%

Profitability (%)

EBITDA Margin 18.0% 18.4% 18.6% 18.8%

APAT Margin 7.0% 7.4% 8.0% 8.4%

ROCE 15.0% 17.4% 18.9% 18.7%

Per Share Data (Rs.)

AEPS 4.7 5.4 6.7 7.7

Reported CEPS 9.5 9.9 11.5 12.9

BVPS 29.6 36.3 42.9 50.4

Valuation

PER (x) 34.8 30.4 24.3 21.3

P/BV (x) 5.5 4.5 3.8 3.2

EV/EBITDA (x) 15.8 14.2 12.3 11.1

MCap/Net Sales (x) 2.4 2.2 2.0 1.8

Turnover

Debtor Days 59 59 59 59

Inventory Days 169 180 181 181

Creditor Days 99 111 111 111

Gearing Ratio

D/E (x) 1.07 0.75 0.65 0.55

Source: Company, Sushil Finance Research Estimates

(16)

16 Oct. 12, 2021

Sushil Financial Services Private Limited

Member : BSE / NSE - SEBI Regn. No. INZ000165135 Research Analyst – SEBI Registration No. INH000000867 Regd. Office : 12, Homji Street, Fort, Mumbai 400 001.

Phone: +91 22 40936000 Fax: +91 22 22665758 Email : [email protected]

Analyst Stock Ownership No

Stock Recommended to Clients Yes

Remuneration/Benefits received from company in 12 months No Merchant Banking Market Making activities / projects No Sushil Financial Services Pvt. Ltd and Group Companies Holding No Sushil Financial Services Pvt. Ltd and Group Directors Holding No

Broking Relationship with the company covered No

Total Expected Return Matrix (Rating and Return) BUY : Over 12% HOLD : 0% to 12% SELL : 0% to -12%

Disclaimer & Disclosures : http://goo.gl/1sOHeV

This report has been furnished to you for your general information only and should not be reproduced, re-circulated, published in any media, website or otherwise, in any form or manner, in part or as a whole, without the express consent in writing of Sushil Financial Services Private Limited. This Research Report is meant solely for use by the original recipient to whom it is sent and is not for circulation. Any unauthorized use, disclosure or public dissemination or copying of information (either whole or partial) contained herein is prohibited.

This Report does not constitute a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual clients. The recommendations, if any, made herein are expression of views and/or opinions and should not be deemed or construed to be neither advice/offer for the purpose of purchase or sale of any securities mentioned herein. Past performance is not a guide for future performance, future returns are not guaranteed. Opinions expressed herein are subject to change without notice. Investor should rely on information/data arising out of their own investigations. The Sushil Equity Universe consists of ## Sushil’s Classic- the company’s where fundamental reports are published and # Sushil’s Bonanza - the other company’s under study.

Investors are advised to seek independent professional advice and arrive at an informed trading/investment decision before executing any trades or making any investments. The price and value of the investments referred to in this material and the income from them may go down as well as up, and investor may realize losses on any investments. This Report has been prepared on the basis of publicly available information, internally developed data and other sources believed by us to be reliable. A graph of daily closing prices of securities is available at www.nseindia.com, www.bseindia.com. Research Analyst views on Subject Company may vary based on Fundamental and Technical Research. Sushil Financial Services Private Limited or its directors, employees, affiliates or representatives do not assume any responsibility for, or warrant the accuracy, completeness, adequacy and reliability of such information / opinions / views. None of the directors, employees, affiliates or representatives of company shall be liable for any direct, indirect, special, incidental, consequential, punitive or exemplary damages/loss etc whatsoever from the information/opinions/views contained in this Report and investors are requested to use the information contained at their risk.

Sushil Financial Services Private Limited (SFSPL) and its connected companies, and their respective Directors, Officers and employees or their relative, may have a long or short position in the subject companies mentioned in the report and it may not be construed as potential conflict of interest with respect to any recommendation and related information and opinions. Reports based on technical and derivative analysis centre on studying charts company’s price movement, outstanding positions and trading volume, as opposed to focusing on a company’s fundamentals and, as such, may not match with a report on a company’s fundamental analysis. SFPSL has different business segments/Divisions with independent research and maintains arm’s length distance catering to different set of customers having various objectives, risk profiles, investment horizon, etc. and therefore may at times have different contrary views on stocks sector and markets. Research Report may differ between SFSPL’s RAs on account of differences in research methodology, personal judgment and difference in time horizons for which recommendations are made. User should keep this risk in mind and not hold - SFSPL, its employees and associates responsible for any losses, damages of any type whatsoever.

This Report is not intended to be a complete statement or summary of the securities, market or developments referred to in this document. SFSPL or its affiliates or employees are under no obligation to update the information. SFSPL or its affiliates or employees shall not be in any way responsible and liable for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report.

SFSPL or its affiliates and/or its employees/its associates or his relative does not have financial interest in the subject companies. SFSPL or its affiliates and/or its employees/its associates or his relative may or may not have beneficial ownership of one per cent or more securities of the subject company, at the end of the month immediately preceding the date of publication of the research report. SFSPL/its Associates/

Research Analyst have not received any compensation from the subject company in the past twelve months. Further the subject company is/was not a client during twelve months preceding the date of distribution of the research report and the types of services provided. SFSPL or its research analyst has not served as an officer, director or employee of the subject company. SFSPL or its affiliates and/or its research analysts have not been engaged in market making activity for the subject company. SFSPL or its associates or its Research Analyst have not received any compensation or other benefits from the subject companies or third party in connection with the research report. SFSPL/its Associates/ Research Analyst/ his Relatives not have any other material conflict of interest at the time of publication of the research report.

SFSPL/its Associates/ Research Analyst have not managed or co-managed public offering of securities, have not received compensation for investment banking or merchant banking or brokerage services, have not received any compensation for product or services other than investment banking or merchant banking or brokerage services from the subject companies in the last twelve months. There is no material disciplinary action that been taken by any regulatory authority impacting equity research analysis activities.

References

Related documents

Liu, et al., Independent no-reflow pre- dictors in female patients with ST-elevation acute myocardial infarction treated with primary percutaneous coronary intervention, Heart Vessels

In that context, it is important to consider that tooth cementum, if well preserved and sampled correctly (Damgaard et al., 2015), can often yield an endog- enous DNA content that

Nadalje, kvačica rasklimava zub nosač, sliježe gingivno prilikom žvakanja te oštećuje parodont i gingivu.(Slika 6) Stoga je kod skraćenog zubnog niza (obostrano ili jednostrano)

In the case of image processing, these features include: computational resource management and intelligent execution scheduling; intelligent and customisable mechanisms

We describe the narrowing-down strategy using 3 panels (a, b, c). We perform LWGS comparison including genome coverage and uniform using YH single cells which are amplified by seven

Subse- quently, to cause the haplotype blocks of the cell, and concomitantly the copy-number information of these haplotype(s), to emerge, the single-cell SNP BAF values are

Of the 384 SNPs selected for genotyping 3,036 samples, 17 were control SNPs for which we had existing genotype data, generated by either TaqMan or Invader methods, with which

In order to determine the effect of whole genome amp- lification (wgaDNA) on SNV detection, we first needed to determine the concordance of SNVs in technical replicates (gDNA); in